Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy.

Couturier CP, Ayyadhury S, Le PU, Nadaf J, Monlong J, Riva G, Allache R, Baig S, Yan X, Bourgey M, Lee C, Wang YCD, Wee Yong V, Guiot MC, Najafabadi H, Misic B, Antel J, Bourque G, Ragoussis J, Petrecca K. · 2020

Read Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. by Couturier CP, Ayyadhury S, Le PU, Nadaf J, Monlong J, Riva G, Allache R, Baig S, Yan X, Bourgey M, Lee C, Wang YCD, Wee Yong V, Guiot MC, Najafabadi H, Misic B, Antel J, Bourque G, Ragoussis J, Petrecca K. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7343844.txt.

Introduction

Couturier and co-authors map the cell family tree inside glioblastoma, a deadly brain cancer, in Nature Communications. They read gene activity in 53,586 single cancer cells and compared it with 22,637 cells from normal fetal brain. The aim was to see how the tumor's mixed cell types relate to each other.

The cancer copies a normal development pattern. Its cells form a three-branch hierarchy centered on glial progenitor-like cells, which resemble young brain support cells. Those progenitors hold most of the dividing cells and, by a motion-tracking method, appear to spawn the other types. Because the hierarchy is now mapped, the authors can point to targets specific to the cancer stem cells at its root.

Catalog record

CREATORCouturier CP, Ayyadhury S, Le PU, Nadaf J, Monlong J, Riva G, Allache R, Baig S, Yan X, Bourgey M, Lee C, Wang YCD, Wee Yong V, Guiot MC, Najafabadi H, Misic B, Antel J, Bourque G, Ragoussis J, Petrecca K.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE121 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7343844

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy By Charles P. Couturier, Shamini Ayyadhury, Phuong U. Le, Javad Nadaf, Jean Monlong, Gabriele Riva, Redouane Allache, Salma Baig, Xiaohua Yan, Mathieu Bourgey, Changseok Lee, Yu Chang David Wang Published in: Nature Communications DOI: 10.1038/s41467-020-17186-5 ABSTRACT Cancer stem cells are critical for cancer initiation, development, and treatment resistance. Our understanding of these processes, and how they relate to glioblastoma heterogeneity, is limited. To overcome these limitations, we performed single-cell RNA sequencing on 53586 adult glioblastoma cells and 22637 normal human fetal brain cells, and compared the lineage hierarchy of the developing human brain to the transcriptome of cancer cells. We find a conserved neural tri-lineage cancer hierarchy centered around glial progenitor-like cells. We also find that this progenitor population contains the majority of the cancer’s cycling cells, and, using RNA velocity, is often the originator of the other cell types. Finally, we show that this hierarchal map can be used to identify therapeutic targets specific to progenitor cancer stem cells. Our analyses show that normal brain development reconciles glioblastoma development, suggests a possible origin for glioblastoma hierarchy, and helps to identify cancer stem cell-specific targets. INTRODUCTION Significant obstacles hampering the development of effective cancer therapeutics include tumor heterogeneity1–5, and the persistence of incompletely understood cancer stem cells (CSCs) that give rise to cancer recurrence6,7. IDH wild-type (IDHwt) glioblastoma, the most common adult primary brain cancer8, exemplifies these obstacles. Following radiotherapy and temozolomide (TMZ) chemotherapy, the median time to recurrence is 7 months, with patients succumbing to the disease 7 months thereafter9,10. This cancer is composed of two main cell compartments: a larger differentiated cell compartment that forms the basis of our understanding of the genomic and molecular underpinnings of the disease11,12; and a smaller, less well-characterized compartment of cells with stem-like capabilities13–16. The molecular and genomic heterogeneity, and the persistence of a subpopulation of cancer cells with stem-like properties following radiotherapy and chemotherapy, are believed to be the main causes of resistance to treatment and the associated extremely poor outcomes6,17,18. Interpatient heterogeneity was established through genomic and transcriptomic analyses by The Cancer Genome Atlas (TCGA) research network11. Analysis of whole-tumor transcriptomic data extracted from predominantly differentiated cells showed that glioblastoma clustered into four main subtypes: proneural; neural; classical; and mesenchymal19. The more recent classification now excludes the neural subtype20. Despite very different transcriptomic profiles and associated genomic alterations, no differences in survival exist between these subtypes. More recently, it has been shown that multiple subtypes coexist in different regions21,22 and different cells12,20 within the same tumor. This interpatient and intratumoral heterogeneity poses a daunting challenge for research programs aimed at developing targeted therapeutic approaches23 and may explain the failures of such approaches in this disease. Although a neurodevelopmental bi-lineage hierarchy has been shown to explain a portion of this heterogeneity in IDH mutant glioma24,25 and high-grade pediatric glioma26, this has not been possible in adult IDHwt glioblastoma. Another layer of complexity was uncovered by the discovery of a small subpopulation of glioblastoma cells that have stem-like properties13,14. The CSC theory is derived from our understanding of normal stem cells15 and posits that such cells must exhibit properties of self-renewal and the ability to produce differentiated progeny. Consistently, glioblastoma stem cells (GSCs) do possess these properties. GSCs can propagate tumors from one host to another14, and can expand and develop to form brain cancers in orthotopic xenograft models that recapitulate the tumor from which they were extracted14,27. Importantly, stem cells isolated from different tumors show variability with respect to marker expression28–30, suggesting that some degree of interpatient and/or intratumoral heterogeneity exists within the stem cell compartment as well. Although the GSC compartment is small in comparison with the differentiated compartment, it is relevant clinically. Studies have shown that GSCs resist radiotherapy6 and TMZ chemotherapy18,31. These data suggest that GSCs may have a role in cancer development and recurrence. There are presently no treatments targeting GSCs. Our understanding of glioblastoma heterogeneity, and the relevance of GSCs in this process, is limited. Here, using massively parallel single-cell RNA-sequencing (scRNAseq) of glioblastoma and the normal developing human brain, we discovered a conserved trilineage cancer hierarchy with progenitor cancer cells at the apex. We found that this progenitor population contains the majority of the cancer’s cycling cells, corresponds to the apex of the hierarchy using RNA velocity, and functionally resemble GSCs. Clinically relevant, we show that this hierarchal map can be used to identify therapeutic targets specific to GSCs. RESULTS ScRNAseq highlights genomic heterogeneity in glioblastoma We used droplet-based scRNAseq32–34 to obtain the transcriptome of cells isolated from freshly excised IDHwt glioblastoma and freshly derived enriched GSCs from IDHwt glioblastoma. In total, 53,586 cells from 16 patients (mean age: 62.3 years (95% CI: 57.0, 67.5); 25% female, Table 1) were sequenced: 30,205 whole-tumor cells and 23,381 enriched GSCs.Table 1Patient and sample information.SampleLocationIDH mutational status1p19q co-deletionATRXMGMT methylationSorting post-dissociationTotal no. of cells (after QC)No. of tumor cells% TumorMedian genes per cellsMedian UMI per cellWhole tumorBT333Right temporal, corpus callosumWTNoWTUnmethylatedYes85261472.1%25616800BT338Right fronto-temporalWTNoNAMethylatedYes2131140465.9%422714,060BT346Right fronto-insularWTNoWTMethylatedYes2180190287.2%347211,332BT363Left frontalWTNoWTUnmethylatedYes10137872686.1%21434998BT364Left parieto-occipitalWTNoNAMethylatedYes7280568878.1%325810,305BT368Left temporalWTNoNAMethylatedYes2647240090.7%29048251BT389Left temporo-insularWTNoWTMethylatedNo4636104922.6%17513732BT390Right temporo-occipitalWTNoWTMethylatedNo3695112430.4%20054718BT397Left frontalWTNoWTUnmethylatedNo64695869.1%24715539BT400Left mesio-temporalWTNoWTUnmethylatedNo5032450889.6%14912813BT402Right fronto-parietalWTNoWTMethylatedNo4953111022.4%25986891BT407Right fronto-temporalWTNoWTUnmethylatedNo38841153.0%22455017BT409Right temporo-parieto-occipitalWTNoWTMethylatedNo247097939.6%21695016GSCBT322Right temporalWTNoWTMethylatedNA3451344099.7%388212,568BT324Left temporalWTNoWTUnmethylatedNA5683484385.2%25296445BT326Right frontalWTNoWTUnmethylatedNA2702269299.6%512523,788BT333Right temporal, corpus callosumWTNoWTUnmethylatedNA5072493097.2%349311,207BT363Left frontalWTNoWTUnmethylatedNA4919405082.3%34109782BT368Left temporalWTNoNAMethylatedNA3470342698.7%30998208 To distinguish cancer cells from normal brain cells, we determined the main copy number aberration (CNA) events in each cell from its transcriptomic profile (Supplementary Fig. 1b, c). Two clusters devoid of known recurrent CNAs, and containing cells from almost all tumors, were identified (Fig. 1a and Supplementary Fig. 1d). Cells in these clusters expressed genes found exclusively in myeloid cells, oligodendrocytes, or endothelial cells (Supplementary Fig. 1e) and were thus classified as normal cells. All other clusters were formed by cells originating mainly from one to three tumors and contained multiple CNAs. We defined these as cancer cells. When enriched GSCs and whole-tumor cells were sequenced from the same patient, these samples clustered together (Fig. 1a and Supplementary Fig. 1f).Fig. 1Single-cell RNA sequencing highlights transcriptomic heterogeneity in glioblastoma and glioblastoma stem cells.a tSNE of location-averaged transcriptome for all tumor cells colored by patient. Cancer cells cluster by patient, whereas normal cells from all patients cluster together (encircled clusters indicated by arrows). GSC corresponds to glioma stem cell samples, W corresponds to whole samples. b Enriched glioblastoma stem cell (GSC) gene expression heatmaps showing relative gene expression (raw data) sorted by PC1 per patient. These maps are separated into three rows: top row—100 genes with the lowest value for PC1 loading; bottom row—100 genes with the highest value for PC1 loading; middle row—100 genes with the highest value for PC2 loading. These gene signatures correspond to neuronal, astrocytic, and progenitor signatures, respectively. The TCGA subtype is also shown for each GSC. c Mean and actual rank of genes by PC1 correlation. The actual gene rank (y axis, one point per sample) correlates strongly with the mean gene rank (x axis) in all patients. d Flow cytometry analysis of GSCs and whole-tumor, demonstrating mutually exclusive expression of CD24 and CD44. e Heatmap of gene expression by cNMF signature with associated cell cycle scores and TCGA subtype (right). The most characteristic genes for each signature group are depicted on the x axis. Signatures (y axis) are ordered according to hierarchical clustering (left tree). Left color bar represents the patient sample that

Read the complete text